Publications by authors named "Eric J Thompson"

Claim this Profile
P
Performance of next-generation sequencing on small tumor specimens and/or low tumor content samples using a commercially available platform.
Scott M Morris, Janakiraman Subramanian, Esma S Gel, George C Runger, Eric J Thompson

PLoS One· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Performance of next-generation sequencing on small tumor specimens and/or low tumor content samples using a commercially available platform.
Scott M Morris, Janakiraman Subramanian, Esma S Gel, George C Runger, Eric J Thompson

PLoS One· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making.
Glen J Weiss, Brandi R Hoff, Robert P Whitehead, Ashish Sangal, Susan A Gingrich, Eric J Thompson

Onco Targets Ther· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic identification of an MHC-binding peptidome from pancreas and breast cancer cell lines.
Kwasi Antwi, Paul D Hanavan, Cheryl E Myers, Yvette W Ruiz, Eric J Thompson

Mol Immunol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosines in the MUC1 cytoplasmic tail modulate transcription via the extracellular signal-regulated kinase 1/2 and nuclear factor-kappaB pathways.
Eric J Thompson, Kandavel Shanmugam, Christine L Hattrup, Kari L Kotlarczyk, Albert Gutierrez

Mol Cancer Res· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional repression of catalase in mouse skin tumor progression.
Kevin A Kwei, Joanne S Finch, Eric J Thompson, G Tim Bowden

Neoplasia· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of action of a dominant negative c-jun mutant in inhibiting activator protein-1 activation.
Eric J Thompson, Ashok Gupta, M Suzanne Stratton, G Tim Bowden

Mol Carcinog· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dominant negative c-jun specifically blocks okadaic acid-induced skin tumor promotion.
Eric J Thompson, Jacalyn MacGowan, Matthew R Young, Nancy Colburn, G Tim Bowden

Cancer Res· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis